Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 19, 2023 - Issue 3
Submit an article Journal homepage
1,168
Views
2
CrossRef citations to date
0
Altmetric
Hepatitis

Effect of the interval between birth and second dose of hepatitis B vaccine on perinatal transmission of hepatitis B virus

Tae Un Yanga Faculty of Medicine, University of Helsinki, Helsinki, FinlandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8229-0977View further author information
ORCID Icon,
Juan C. Vargas-Zambranob Global Medical, Sanofi, Lyon, FranceORCID Iconhttps://orcid.org/0000-0002-5609-7046View further author information
ORCID Icon,
Hang A Parkc Department of Public Health, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea;d Department of Emergency Medicine, Hallym University, Dongtan Sacred Heart Hospital, Hwaseong, Republic of KoreaView further author information
,
Chae Won Junge National Institute of Organ, Tissue and Blood Management, Ministry of Health and Welfare, Seoul, Republic of KoreaView further author information
,
Dongwook Kimf Division of Immunization, Bureau of Healthcare Safety and Immunization, Korea Disease Control and Prevention Agency, Cheongju, Republic of KoreaView further author information
&
Youngmee Jeeg Korea Disease Control and Prevention Agency, Cheongju, Republic of KoreaView further author information
Article: 2278940 | Received 16 Aug 2023, Accepted 31 Oct 2023, Published online: 13 Nov 2023

References

  • World Health Organization. Interim guidance for country validation of viral hepatitis elimination. Geneva: World Health Organization; 2021.
  • Nayagam S, Thursz M, Sicuri E, Conteh L, Wiktor S, Low-Beer D, Hallet TB. Requirements for global elimination of hepatitis B: a modelling study. Lancet Infect Dis. 2016;16(12):1399–5. doi:10.1016/S1473-3099(16)30204-3.
  • Beasley RP, Hwang LY, Lee GC, Lan CC, Roan CH, Huang FY, Chen CL. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet. 1983;2(8359):1099–102. doi:10.1016/s0140-6736(83)90624-4.
  • World Health Organization. Hepatitis B vaccines: WHO position paper - July 2017. Wkly Epidemiol Rec. 2017;92(27):369–92. https://www.who.int/publications/i/item/WER9227.
  • Yang TU, Jung CW, Kim D, Park HA, Jee Y. Impact of the national perinatal hepatitis B prevention programme in the Republic of Korea: a retrospective registry-based cohort study. Vaccine. 2020;38(34):5532–40. doi:10.1016/j.vaccine.2020.05.044.
  • World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2020 global summary. Geneva: World Health Organization; 2020.
  • Taiwan Centers for Disease Control. Current immunization schedule in Taiwan, 2019. https://www.cdc.gov.tw/Uploads/archives/3604cd18-8c64-4a49-a7c5-1b43df2f3f5b.pdf.
  • Stevens CE, Toy P, Kamili S, Taylor PE, Tong MJ, Xia GL, Vyas GN. Eradicating hepatitis B virus: the critical role of preventing perinatal transmission. Biologicals. 2017;50:3–19. doi:10.1016/j.biologicals.2017.08.008.
  • Tharmaphornpilas P, Rasdjarmrearnsook AO, Plianpanich S, Sa-Nguanmoo P, Poovorawan Y. Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination. Vaccine. 2009;27(44):6110–5. doi:10.1016/j.vaccine.2009.08.034.
  • Funk AL, Lu Y, Yoshida K, Zhao T, Boucheron P, van Holten J, Chou R, Bulterys M, Shimakawa Y. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(1):70–84. doi:10.1016/S1473-3099(20)30586-7.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.